Conexiant
Login
  • Corneal Physician
  • Glaucoma Physician
  • New Retinal Physician
  • Ophthalmology Management
  • Ophthalmic Professional
  • Presbyopia Physician
  • Retinal Physician
The Ophthalmologist
  • Explore

    Explore

    • Latest
    • Insights
    • Case Studies
    • Opinion & Personal Narratives
    • Research & Innovations
    • Product Profiles

    Featured Topics

    • Anterior Segment
    • Glaucoma
    • Retina

    Issues

    • Latest Issue
    • Archive
  • Subspecialties
    • Cataract
    • Cornea
    • Glaucoma
    • Neuro-ophthalmology
    • Oculoplastics
    • Optometry
    • Pediatric
    • Retina
  • Business

    Business & Profession

    • Professional Development
    • Business and Entrepreneurship
    • Practice Management
    • Health Economics & Policy
  • Training & Education

    Career Development

    • Professional Development
    • Career Pathways

    Events

    • Webinars
    • Live Events
  • Events
    • Live Events
    • Webinars
  • Community

    People & Profiles

    • Power List
    • Voices in the Community
    • Authors & Contributors
  • Multimedia
    • Video
Subscribe
Subscribe

False

Advertisement
The Ophthalmologist / Issues / 2025 / Mar / Glaucoma Patients in the Dark on Preservative-Free Treatments
Glaucoma

Glaucoma Patients in the Dark on Preservative-Free Treatments

Preservative Freedom Coalition announces results of study of 558 US glaucoma patients

3/13/2025 2 min read

Share


0325-008 [AI news] Glaucoma Survey_In Article 1.png

The Preservative Freedom Coalition – comprising members from Dry Eye University, The Glaucoma Foundation, Intrepid Eye Society, the National Medical Association of Ophthalmology Section, Real World Ophthalmology, and Thea Pharma Inc. – has announced the results of a US survey looking at the experience of glaucoma patients.

A total of 558 responses were received from individuals diagnosed with open-angle glaucoma or ocular hypertension across the United States. More than half of respondents had been living with their condition for seven years or more, with the majority (>75 percent) indicating early/mild or moderate stages as described by their physician.

The survey revealed:

  • Only one in five respondents were satisfied with their current treatment.

  • Patients expressed concerns about the toxicity of preservatives (60 percent) and disease progression (39 percent), indicating there may be an openness to discussing new treatment options.

  • Almost two-thirds (61 percent) of patients reported they were unaware of preservative-free treatment alternatives.

  • While most patients (82 percent) expressed significant trust in their physicians, nearly half (49 percent) of those not using preservative-free options reported a lack of recommendations from their doctors

"The most surprising revelation […] was that the majority of patients with glaucoma were not aware of their preservative-free options, despite their availability on the market,” said Elena Sturman, President and CEO of The Glaucoma Foundation. “This is crucial because it reinforces the importance of having these conversations with patients and empowering them to take control of their ocular health, potentially mitigating side effects."

The Preservative Freedom Coalition conducted the Glaucoma Patient Experience survey to gather insights from adults 18 years or older living with primary open-angle glaucoma or ocular hypertension. The aim of the survey was to understand their experience, treatment histories, and awareness of preservative-free treatment options.

For more information about The Preservative Freedom Coalition, visit: www.preservativefreedom.com.

Related Content

Newsletters

Receive the latest Ophthalmology news, personalities, education, and career development – weekly to your inbox.

Newsletter Signup Image

False

Advertisement

False

Advertisement

Explore More in Ophthalmology

Dive deeper into the world of Ophthalmology. Explore the latest articles, case studies, expert insights, and groundbreaking research.

False

Advertisement
The Ophthalmologist
Subscribe

About

  • About Us
  • Work at Conexiant Europe
  • Terms and Conditions
  • Privacy Policy
  • Advertise With Us
  • Contact Us

Copyright © 2025 Texere Publishing Limited (trading as Conexiant), with registered number 08113419 whose registered office is at Booths No. 1, Booths Park, Chelford Road, Knutsford, England, WA16 8GS.

Disclaimer

The Ophthalmologist website is intended solely for the eyes of healthcare professionals. Please confirm below: